Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development?

doi:10.1016/j.healun.2012.02.034

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development?

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 1 Aug 2012

Pantou Malena P, Manginas Athanasios, Alivizatos Peter A, Degiannis Dimitrios

Abstract excerpt

BACKGROUND: Connective tissue growth factor (CTGF) has been reported to be upregulated in experimental models of chronic cardiac allograft rejection. We investigated the contribution of CTGF to the development of cardiac allograft vasculopathy (CAV), a surrogate marker for chronic rejection. METHODS: This prospective study included 72 adult heart allograft recipients. Genotyping of the rs6918698 polymorphism was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective Tissue Growth Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Everolimus

Share to Graft Rejection

Share to Heart Transplantation

Share to Immunosuppressive Agents

Share to Sirolimus

Share to Transplantation, Homologous

Share to Vascular Diseases

Source

Open in PubMed

Identifiers

PMID: 22503846
DOI: 10.1016/j.healun.2012.02.034

Genes

CCN2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Connective tissue growth factor (CTGF/CCN2): a protagonist in cardiac allograft vasculopathy development?PMID 22503846Read ↗

Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.Semantic proximity Read ↗

Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation.Semantic proximity Read ↗

Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.Semantic proximity Read ↗

Transforming growth factor-beta polymorphisms and cardiac allograft rejection.Semantic proximity Read ↗

Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.Semantic proximity Read ↗

CCR5, RANTES and CX3CR1 polymorphisms: possible genetic links with acute heart rejection.Semantic proximity Read ↗

HLA-G +3196 polymorphism as a risk factor for cell mediated rejection following heart transplant.Semantic proximity Read ↗

The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation.Semantic proximity Read ↗

Transforming growth factor-beta1 and lung allograft fibrosis.Semantic proximity Read ↗

The Impact of Transforming Growth Factor-β1 Gene Polymorphism on End-Stage Renal Failure After Heart TransplantationSemantic proximity Read ↗

Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.Semantic proximity Read ↗

Association of Transforming Growth Factor-β1 rs1982073 Polymorphism with Susceptibility to Acute Renal Rejection: a Systematic Review and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.